Mechanisms of Resistance of Malaria Parasites to Antifolates

A Molecular Marker for Chloroquine-Resistant Falciparum Malaria

Djimdé, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourté, Y., Coulibaly, D., Dicko, A., Su, X.-Z., Nomura, T., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440403 · Cited by 1,010

The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden

Breman, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.1 · Cited by 931

Drug development for neglected diseases: a deficient market and a public-health policy failure

Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R., & Ford, N. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09096-7 · Cited by 893

Chloroquine‐Resistant Malaria

Wellems, T. E., & Plowe, C. V. (2001) · The Journal of Infectious Diseases · doi:10.1086/322858 · Cited by 807

Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum

Wootton, J. C., Feng, X., Ferdig, M. T., Cooper, R. A., Mu, J., Baruch, D. I., Magill, A. J., & Su, X.-Z. (2002) · Nature · doi:10.1038/nature00813 · Cited by 722

Pyrimethamine and Proguanil Resistance-Conferring Mutations in Plasmodium falciparum Dihydrofolate Reductase: Polymerase Chain Reaction Methods for Surveillance in Africa

Plowe, C. V., Djimde, A., Bouare, M., Doumbo, O., & Wellems, T. E. (1995) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1995.52.565 · Cited by 674

Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.

Peterson, D. S., Walliker, D., & Wellems, T. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9114 · Cited by 653

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

White, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1413 · Cited by 575

PENICILUNASE-PRODUCING NEISSERIA GONORRH$OElig;q

ASHFORD, W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92467-3 · Cited by 557

Chemotherapy and drug resistance in malaria

Peters, W. (1970) · Medical Entomology and Zoology · Cited by 551

Averting a malaria disaster

White, N., Nosten, F., Looareesuwan, S., Watkins, W., Marsh, K., Snow, R., Kokwaro, G., Ouma, J., Hien, T., Molyneux, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07367-x · Cited by 543

Artesunate combinations for treatment of malaria: meta-analysis

(2004) · The Lancet · doi:10.1016/s0140-6736(03)15162-8 · Cited by 538

Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum.

Cowman, A. F., Morry, M. J., Biggs, B. A., Cross, G. A., & Foote, S. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9109 · Cited by 526

Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment of Plasmodium falciparum Malaria

Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. D., Malkin, E. M., Cortese, J. F., Martino, L. M., Mukadam, R. A. G., Rogerson, S. J., Lescano, A. G., Molyneux, M. E., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338566 · Cited by 523

Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil

Fidock, D. A., & Wellems, T. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10931 · Cited by 518

Intercontinental Spread of Pyrimethamine-Resistant Malaria

Roper, C., Pearce, R., Nair, S., Sharp, B., Nosten, F., & Anderson, T. (2004) · Science · doi:10.1126/science.1098876 · Cited by 510

The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity.

Peters, W. (1975) · PubMed · Cited by 488

Effects of artemisinin derivatives on malaria transmissibility

Price, R. N., Nosten, F., Luxemburger, C., ter Kuile, F. O., Paiphun, L., Price, R. N., Luxemburger, C., Chongsuphajaisiddhi, T., White, N. J., Price, R. N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91488-9 · Cited by 462

Evidence for the shikimate pathway in apicomplexan parasites

Roberts, F., Roberts, C. W., Johnson, J. J., Kyle, D. E., Krell, T., Coggins, J. R., Coombs, G. H., Milhous, W. K., Tzipori, S., Ferguson, D. J. P., et al. (1998) · Nature · doi:10.1038/31723 · Cited by 452

Impact of chloroquine resistance on malaria mortality

Trape, J.-F., Pison, G., Preziosi, M.-P., Enel, C., du Loû, A. D., Delaunay, V., Samb, B., Lagarde, E., Molez, J.-F., & Simondon, F. (1998) · Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(98)80009-7 · Cited by 452

The chemotherapy of rodent malaria, XXII: The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity

Peters, W., Portus, J. H., & Robinson, B. L. (1975) · Annals of Tropical Medicine & Parasitology · doi:10.1080/00034983.1975.11686997 · Cited by 428

Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum

Triglia, T., Menting, J. G. T., Wilson, C., & Cowman, A. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13944 · Cited by 422

Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.

Peterson, D. S., Milhous, W. K., & Wellems, T. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3018 · Cited by 419

Insights into antifolate resistance from malarial DHFR-TS structures

Yuvaniyama, J., Chitnumsub, P., Kamchonwongpaisan, S., Vanichtanankul, J., Sirawaraporn, W., Taylor, P., Walkinshaw, M. D., & Yuthavong, Y. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb921 · Cited by 419

Mutations in Plasmodium falciparum Dihydrofolate Reductase and Dihydropteroate Synthase and Epidemiologic Patterns of Pyrimethamine‐Sulfadoxine Use and Resistance

Plowe, C. V., Cortese, J. F., Djimde, A., Nwanyanwu, O. C., Watkins, W. M., Winstanley, P. A., Estrada‐Franco, J. G., Mollinedo, R. E., Avila, J. C., Cespedes, J. L., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514159 · Cited by 414

Transfection of Plasmodium falciparum within human red blood cells.

Wu, Y., Sifri, C. D., Lei, H. H., Su, X., & Wellems, T. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.973 · Cited by 390

Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.

Wu, Y., Kirkman, L. A., & Wellems, T. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1130 · Cited by 378

Outpatient Waiting Time

(1963) · The Lancet · doi:10.1016/s0140-6736(63)90800-6 · Cited by 370

Sequence Variation of the Hydroxymethyldihydropterin Pyrophosphokinase: Dihydropteroate Synthase Gene in Lines of the Human Malaria Parasite, Plasmodium falciparum , with Differing Resistance to Sulfadoxine

Brooks, D. R., Wang, P., Read, M., Watkins, W. M., Sims, P. F. G., & Hyde, J. E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00397.x · Cited by 369

Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?

Sibley, C. H., Hyde, J. E., Sims, P. F. G., Plowe, C. V., Kublin, J. G., Mberu, E. K., Cowman, A. F., Winstanley, P. A., Watkins, W. M., & Nzila, A. M. (2001) · Trends in Parasitology · doi:10.1016/s1471-4922(01)02085-2 · Cited by 369

The Wider World

Loraine, J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)93011-6 · Cited by 357

Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase

Sirawaraporn, W., Sathitkul, T., Sirawaraporn, R., Yuthavong, Y., & Santi, D. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1124 · Cited by 341

A Selective Sweep Driven by Pyrimethamine Treatment in Southeast Asian Malaria Parasites

Nair, S. (2003) · Molecular Biology and Evolution · doi:10.1093/molbev/msg162 · Cited by 308

Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

Wang, P., Read, M., Sims, P. F. G., & Hyde, J. E. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2821646.x · Cited by 307

Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum.

Triglia, T., & Cowman, A. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7149 · Cited by 304

Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.

Foote, S. J., Galatis, D., & Cowman, A. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3014 · Cited by 301

A Mechanism for the Synergistic Antimalarial Action of Atovaquone and Proguanil

Srivastava, I. K., & Vaidya, A. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1334 · Cited by 299

The Anaemia of P. falciparum Malaria

Abdalla, S., Weatherall, D. J., Wickramasinghe, S. N., & Hughes, M. (1980) · British Journal of Haematology · doi:10.1111/j.1365-2141.1980.tb05956.x · Cited by 292

Plasmodium falciparum: In Vitro Studies of the Pharmacodynamic Properties of Drugs Used for the Treatment of Severe Malaria

Terkuile, F., White, N. J., Holloway, P., Pasvol, G., & Krishna, S. (1993) · Experimental Parasitology · doi:10.1006/expr.1993.1010 · Cited by 290

Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum.

Crabb, B. S., & Cowman, A. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7289 · Cited by 289

Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria

Triglia, T., Wang, P., Sims, P. F. G., Hyde, J. E., & Cowman, A. F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.3807 · Cited by 273

Malaria-a neglected disease?

Marsh, K. (1992) · Parasitology · doi:10.1017/s0031182000075247 · Cited by 268

Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins

Wang, P., Lee, C.-S., Bayoumi, R., Djimde, A., Doumbo, O., Swedberg, G., Dao, L. D., Mshinda, H., Tanner, M., Watkins, W. M., et al. (1997) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(97)00114-x · Cited by 261

Observations on Two Plasmodium Falciparum Infections with an Abnormal Response to Chloroquine

Moore, D. V., & Lanier, J. E. (1961) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1961.10.5 · Cited by 259

Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene.

Bzik, D. J., Li, W. B., Horii, T., & Inselburg, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8360 · Cited by 258

Stable Transfection of Malaria Parasite Blood Stages

van Dijk, M. R., Waters, A. P., & Janse, C. J. (1995) · Science · doi:10.1126/science.7761856 · Cited by 253

Variations in frequencies of drug resistance in Plasmodium falciparum

Rathod, P. K., McErlean, T., & Lee, P.-C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9389 · Cited by 250

Interactions of Atovaquone with Other Antimalarial Drugs against Plasmodium falciparum in Vitro

Canfield, C. J., Pudney, M., & Gutteridge, W. E. (1995) · Experimental Parasitology · doi:10.1006/expr.1995.1049 · Cited by 247

Artesunate Reduces but Does Not Prevent Posttreatment Transmission of Plasmodium falciparum to Anopheles gambiae

Targett, G., Drakeley, C., Jawara, M., von Seidlein, L., Coleman, R., Deen, J., Pinder, M., Doherty, T., Sutherland, C., Walraven, G., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/319689 · Cited by 239

Mefloquine-resistant falciparum malaria on the Thai-Burmese border

Nosten, F., ter Kuile, F., Chongsuphajaisiddhi, T., White, N. J., ter Kuile, F., Luxemburger, C., Webster, H. K., Edstein, M., Phaipun, L., Lay Thew, K., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92798-7 · Cited by 237

Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum : Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites

Nzila, A. M., Mberu, E. K., Sulo, J., Dayo, H., Winstanley, P. A., Sibley, C. H., & Watkins, W. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.991-996.2000 · Cited by 232

Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria

Fivelman, Q. L., Butcher, G. A., Adagu, I. S., Warhurst, D. C., & Pasvol, G. (2002) · Malaria Journal · doi:10.1186/1475-2875-1-1 · Cited by 225

Part-time nursing.

Shee, W., & Hk, C. (1947) · PubMed · Cited by 212

TEN UNORTHODOX PERSPECTIVES ON EVOLUTION PROMPTED BY COMPARATIVE POPULATION GENETIC FINDINGS ON MITOCHONDRIAL DNA

Avise, J. C. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.000401 · Cited by 210

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

Watkins, W. M., & Mosobo, M. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90431-o · Cited by 209

The evolution of drug–resistant malaria: the role of drug elimination half–life

Hastings, I. M., Watkins, W. M., & White, N. J. (2002) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2001.1036 · Cited by 202

BREAST-FED BABIES WHO FAIL TO THRIVE

Stanway, P., & Whichelow, M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91340-0 · Cited by 201

In vitro activities of and mechanisms of resistance to antifol antimalarial drugs

Milhous, W. K., Weatherly, N. F., Bowdre, J. H., & Desjardins, R. E. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.4.525 · Cited by 198

Plasmodium berghei Dihydrofolate Reductase Isolation, Properties, and Inhibition by Antifolates

FERONE, R., BURCHALL, J. J., & HITCHINGS, G. H. (1969) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14644-0 · Cited by 184

Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria

Djimdé, A., Doumbo, O. K., Steketee, R. W., & Plowe, C. V. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06040-8 · Cited by 179

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

Mutabingwa, T., Nzila, A., Mberu, E., Nduati, E., Winstanley, P., Hills, E., & Watkins, W. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06344-9 · Cited by 178

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial

Hien, T. T., Dolecek, C., Mai, P. P., Dung, N. T., Truong, N. T., Thai, L. H., Hoai An, D. T., Thanh, T. T., Stepniewska, K., White, N. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15163-x · Cited by 178

Origin and Dissemination of Plasmodium falciparum Drug‐Resistance Mutations in South America

Cortese, J. F., Caraballo, A., Contreras, C. E., & Plowe, C. V. (2002) · The Journal of Infectious Diseases · doi:10.1086/342946 · Cited by 177

Combination therapy for malaria in Africa: hype or hope?

Bloland, P. B., Ettling, M., & Meek, S. R. (2000) · PubMed · doi:10.1590/s0042-96862000001200005 · Cited by 172

Transfection of Plasmodiium falciparum within human red biood cells

Wu, Y. (1995) · Medical Entomology and Zoology · Cited by 162

CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN THAILAND

Harinasuta, T., Suntharasamai, P., & Viravan, C. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90395-8 · Cited by 158

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

Watkins, W. M., Mberu, E. K., Winstanley, P., & Plowe, C. V. (1997) · Parasitology Today · doi:10.1016/s0169-4758(97)01124-1 · Cited by 158

Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum

Basco, L. K., de Pécoulas, P. E., Wilson, C. M., Bras, J. L., & Mazabraud, A. (1995) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(94)00207-4 · Cited by 156

The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase.

Roland, S., Ferone, R., Harvey, R. J., Styles, V. L., & Morrison, R. W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86714-5 · Cited by 148

Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria

van Hensbroek, M. B., Morris-Jones, S. D., Meisner, S., Jaffar, S. S., Bayo, L., Dackour, R., Phillips, C. B., & Greenwood, B. M. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90438-7 · Cited by 148

P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates

Plowe, C. V., Kublin, J. G., & Doumbo, O. K. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80014-9 · Cited by 147

Divergent Regulation of Dihydrofolate Reductase Between Malaria Parasite and Human Host

Zhang, K., & Rathod, P. K. (2002) · Science · doi:10.1126/science.1068274 · Cited by 144

Plasmodium falciparum crossresistance between trimethoprim and pyrimethamine

Iyer, J. K., Milhous, W. K., Cortese, J. F., Kublin, J. G., & Plowe, C. V. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06201-8 · Cited by 143

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives

White, N. J. (1994) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(94)90471-5 · Cited by 140

Crystal structure of Mycobacterium tuberculosis 6-hydroxymethyl-7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action

Baca, A. M., Sirawaraporn, R., Turley, S., Sirawaraporn, W., & Hol, W. G. J. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4094 · Cited by 138

The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites

Hyde, J. E. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90017-v · Cited by 137

Chloroquine-resistant Plasmodium falciparum malaria in Kenya

Fogh, S., Jepsen, S. V., & Effersøe, P. (1979) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(79)90220-7 · Cited by 137

Synergistic Antimalarial Activity of Pyrimethamine and Sulfadoxine against Plasmodium falciparum In Vitro

Chulay, J. D., Watkins, W. M., & Sixsmith, D. G. (1984) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1984.33.325 · Cited by 137

Molecular Evidence of Greater Selective Pressure for Drug Resistance Exerted by the Long‐Acting Antifolate Pyrimethamine/Sulfadoxine Compared with the Shorter‐Acting Chlorproguanil/Dapsone on KenyanPlasmodium falciparum

Nzila, A. M., Nduati, E. W., Mberu, E. K., Sibley, C. H., Monks, S. A., Winstanley, P., & Watkins, W. M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315520 · Cited by 134

PS-15: a Potent, Orally Active Antimalarial from a New Class of Folic Acid Antagonists

Canfield, C. J., Milhous, W. K., Ager, A. L., Rossan, R. N., Sweeney, T. R., Lewis, N. J., & Jacobus, D. P. (1993) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.49.121 · Cited by 124

Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum

Zolg, J. W., Plitt, J. R., Chen, G.-X., & Palmer, S. (1989) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(89)90173-4 · Cited by 119

Antimalarial compounds: from bench to bedside

Olliaro, P., & Taylor, W. R. J. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00653 · Cited by 117

Folate metabolism in malaria.

Ferone, R. (1977) · PubMed · Cited by 117

Point Mutations in the Dihydrofolate Reductase and Dihydropteroate Synthetase Genes and in Vitro Susceptibility to Pyrimethamine and Cycloguanil of Plasmodium falciparum Isolates from Papua New Guinea

Reeder, J. C., Rieckmann, K. H., Genton, B., Lorry, K., Wines, B., & Cowman, A. F. (1996) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.209 · Cited by 116

Models to predict the intensity of Plasmodium falciparum transmission: applications to the burden of disease in Kenya

Snow, R. W., Gouws, E., Omumbo, J., Rapuoda, B., Craig, M., Tanser, F. C., SUEUR, D. L., & Ouma, J. H. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90781-7 · Cited by 113

Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire.

Greenberg, A. E., Ntumbanzondo, M., Ntula, N., Mawa, L., Howell, J., & Davachi, F. (1989) · Europe PMC (PubMed Central) · Cited by 112

Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100.

Dallas, W. S., Gowen, J. E., Ray, P. H., Cox, M. J., & Dev, I. K. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.18.5961-5970.1992 · Cited by 111

Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy

McGready, R., Brockman, A., Cho, T., Cho, D., van Vugt, M., Luxemburger, C., Chongsuphajaisiddhi, T., White, N. J., & Nosten, F. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90235-9 · Cited by 110

Kenyan Plasmodium falciparum Field Isolates: Correlation between Pyrimethamine and Chlorcycloguanil Activity In Vitro and Point Mutations in the Dihydrofolate Reductase Domain

Nzila-Mounda, A., Mberu, E. K., Sibley, C. H., Plowe, C. V., Winstanley, P., & Watkins, W. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.164 · Cited by 110

High-Dose Mefloquine in the Treatment of Multidrug-Resistant Falciparum Malaria

ter Kuile, F. O., Nosten, F. H., Thieren, M., Luxemburger, C., Edstein, M. D., Chongsuphajaisiddhi, T., Phaipun, L., Webster, H. K., & White, N. J. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1393 · Cited by 110

Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes

Figtree, M. C., Pasay, C. J., Slade, R., Cheng, Q., Cloonan, N., Walker, J. C., & Saul, A. J. (2000) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(00)00204-8 · Cited by 106

Stage Specific Actions of Antimalarial Drugs on Plasmodium falciparum in Culture

Geary, T. G., DIVO, A. A., & Jensen, J. B. (1989) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.40.240 · Cited by 105

The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase. Gene synthesis, expression, and anti-folate-resistant mutants.

Worachart Sirawaraporn, A., Prapunwattana, P., Rachada Sirawaraporn, A., Yuthavong, Y., & Santi, D. V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80589-4 · Cited by 103

Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa

Brasseur, P., Guiguemdé, R. T., Diallo, S., Guiyedi, V., Kombila, M., Ringwald, P., & Olliaro, P. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90083-4 · Cited by 102

Basis for antifolate action and resistance in malaria

Yuthavong, Y. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(01)01525-8 · Cited by 100

Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?

Omar, S. A., Adagu, I. S., & Warhurst, D. C. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90250-0 · Cited by 98

Molecular assays for surveillance of antifolate-resistant malaria

Kublin, J. G., WITZIG, R. S., Shankar, A. H., Zurita, J. Q., Gilman, R. H., Guarda, J. A., Cortese, J. F., & Plowe, C. V. (1998) · The Lancet · doi:10.1016/s0140-6736(98)24022-0 · Cited by 97

Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy

Wang, P., Brobey, R. K. B., Horii, T., Sims, P. F. G., & Hyde, J. E. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01437.x · Cited by 94

Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast

Cortese, J. F., & Plowe, C. V. (1998) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(98)00075-9 · Cited by 93

Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study

Plowe, C. V., Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D., Chimpeni, P., Molyneux, M. E., & Taylor, T. E. (2004) · BMJ · doi:10.1136/bmj.37977.653750.ee · Cited by 93

Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia

Nagesha, H. S., Din-Syafruddin, Casey, G. J., Susanti, A. I., Fryauff, D. J., Reeder, J. C., & Cowman, A. F. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90329-3 · Cited by 88

Prevalence of the Dihydrofolate Reductase Asn-108 Mutation as the Basis for Pyrimethamine-Resistant Falciparum Malaria in the Brazilian Amazon

Peterson, D. S., Santi, S. M. D., Póvoa, M. M., Calvosa, V. S. P., do Rosário, V. E., & Wellems, T. E. (1991) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.45.492 · Cited by 86

Malaria in Tanzania.

CLYDE, D. F. (1967) · Cited by 86

Malaria chemoprophylaxis with chloroquine in young Nigerian children

Bradley-Moore, A. M., Greenwood, B. M., Bradley, A. K., et al. (1985) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1985.11811962 · Cited by 86

Treatment of Uncomplicated Multidrug‐Resistant Falciparum Malaria with Artesunate‐Atovaquone‐Proguanil

van Vugt, M., Leonardi, E., Phaipun, L., Slight, T., Thway, K. L., McGready, R. M., Brockman, A., Villegas, L., Looareesuwan, S., White, N. J., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/344901 · Cited by 82

In Vivo Selection for a Specific Genotype of Dihydropteroate Synthetase ofPlasmodium falciparumby Pyrimethamine‐Sulfadoxine but Not Chlorproguanil‐Dapsone Treatment

Curtis, J., Duraisingh, M. T., & Warhurst, D. C. (1998) · The Journal of Infectious Diseases · doi:10.1086/517831 · Cited by 79

The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria.

Schellenberg, D. M., Kahigwa, E., DRAKELEY, C. J., Malende, A., Wigayi, J., Msokame, C., Aponte, J. J., Tanner, M., Mshinda, H., Menéndez, C., et al. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.67.17 · Cited by 79

The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues

Reeves, D. S., & Wilkinson, P. J. (1979) · Infection · doi:10.1007/bf01639009 · Cited by 77

VALIDATION OF A SIMPLIFIED METHOD FOR USING MOLECULAR MARKERS TO PREDICT SULFADOXINE-PYRIMETHAMINE TREATMENT FAILURE IN AFRICAN CHILDREN WITH FALCIPARUM MALARIA

Kyabayinze, D., Cattamanchi, A., Kamya, M. R., Rosenthal, P. J., & Dorsey, G. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.69.247 · Cited by 77

The Evaluation of Sulfonamides, Alone or in Combination with Pyrimethamine, in the Treatment of Multi-Resistant Falciparum Malaria

Chin, W., Contacos, P. G., Coatney, G. R., et al. (1966) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1966.15.823 · Cited by 76

CHANGES IN MALARIA INCIDENCE AFTER MASS DRUG ADMINISTRATION IN NICARAGUA

Garfield, R., & Vermund, S. H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90523-8 · Cited by 75

COMPARATIVE EFFICACY OF AMINOQUINOLINE-ANTIFOLATE COMBINATIONS FOR THE TREATMENT OF UNCOMPLICATED FALCIPARUM MALARIA IN KAMPALA, UGANDA

Gasasira, A. F., Dorsey, G., Nzarubara, B., Staedke, S. G., Nassali, A., Rosenthal, P. J., & Kamya, M. R. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.127 · Cited by 73

A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance

WANG, P., Sims, P. F. G., & Hyde, J. E. (1997) · Parasitology · doi:10.1017/s0031182097001431 · Cited by 72

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

Winstanley, P., Watkins, W. M., Muhia, D. K., Szwandt, S., Amukoye, E., & Marsh, K. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90093-6 · Cited by 71

De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum

Krungkrai, J., Webster, H. K., & Yuthavong, Y. (1989) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(89)90126-6 · Cited by 71

SULPHORMETHOXINE IN CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN THAILAND

Harinasuta, T., Viravan, C., & REID, H. A. (1967) · The Lancet · doi:10.1016/s0140-6736(67)91703-5 · Cited by 71

The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non‐severe falciparum malaria.

Winstanley, P., Watkins, W. M., Newton, C. R. J. C., Nevill, C. G., Mberu, E. K., Warn, P. A., Waruiru, C., Mwangi, I., Warrell, D., & Marsh, K. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04016.x · Cited by 69

Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA

Lin, X. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.6.1381 · Cited by 68

The mechanism of resistance to sulfa drugs in Plasmodium falciparum

Triglia, T., & Cowman, A. F. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0060 · Cited by 67

Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum

Sirawaraporn, W., Sirawaraporn, R., Cowman, A. F., Yuthavong, Y., & Santi, D. V. (1990) · Biochemistry · doi:10.1021/bi00500a009 · Cited by 67

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial

Sulo, J., Chimpeni, P., Hatcher, J., Kublin, J. G., Plowe, C. V., Molyneux, M., Marsh, K., Te, T., Watkins, W. M., & Winstanley, P. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11198-6 · Cited by 67

Potentiation of pyrimethamine by sulphadiazine in human malaria

Hurly, M. G. D. (1959) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(59)90044-6 · Cited by 66

Monitoring antimalarial drug resistance (report of a WHO Consultation)

Bloland, P. B., D’Alessandro, U., Ringwald, P., Watkins, W. M., & Al), E. (2011) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · doi:10.17037/pubs.00004979 · Cited by 65

Stage specific protein and nucleic acid synthesis during the asexual cycle of the rodent malaria Plasmodium chabaudi

Newbold, C., Boyle, D. B., Smith, C. C., & Brown, K. N. (1982) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(82)90004-4 · Cited by 65

Plasmodium Falciparum Resistant to Chloroquine in Cambodia

Eyles, D. E., Hoo, C. C., Warren, M., et al. (1963) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1963.12.840 · Cited by 64

Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.

Nosten, F. H., Imvithaya, S., Vincenti, M., Delmas, G., Lebihan, G., Häusler, B., & White, N. J. (1987) · PubMed Central · Cited by 63

Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali.

Diourte, Y., Djimdé, A., Doumbo, O. K., Sagara, I., Coulibaly, Y., Dicko, A., Diallo, M., Diakité, M., Cortese, J. F., & Plowe, C. V. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.60.475 · Cited by 63

DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHASE GENOTYPES ASSOCIATED WITH IN VITRO RESISTANCE OF PLASMODIUM FALCIPARUM TO PYRIMETHAMINE, TRIMETHOPRIM, SULFADOXINE, AND SULFAMETHOXAZOLE

Khalil, I. F., Rønn, A. M., Alifrangis, M., GABAR, H. A., Satti, G. M. H., & Bygbjerg, I. C. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.586 · Cited by 59

Treatment of Malaria in Vietnam with Oral Artemisinin

Ds, N., Bh, D., Pd, N., Vh, N., Binh, L. N., Vs, M., & Meshnick, S. R. (1993) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.48.398 · Cited by 57

Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania

Jelínek, T., Jelínek, T., Rønn, A. M., Lemnge, M. M., Curtis, J., Mhina, J. A., Duraisingh, M. T., Bygbjerg, I. C., & Warhurst, D. C. (1998) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1998.00280.x · Cited by 57

Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area

Omar, S. A., Adagu, I. S., Gump, D. W., Ndaru, N. P., & Warhurst, D. C. (2001) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034980120103234 · Cited by 56

Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand

Looareesuwan, S., Wilairatana, P., Vanijanonta, S., Kyle, D. E., & Webster, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)91690-a · Cited by 55

Molecular Diagnosis of Resistance to Antimalarial Drugs during Epidemics and in War Zones

DJIMDÉ, A. A., Dolo, A., Ouattara, A., Diakité, S., Plowe, C. V., & Doumbo, O. K. (2004) · The Journal of Infectious Diseases · doi:10.1086/422758 · Cited by 54

Single dose pharmacokinetics of proguanil and its metabolites in pregnancy

Wangboonskul, J., White, N. J., Nosten, F. H., ter Kuile, F. O., Moody, R. R., & Taylor, R. B. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00271366 · Cited by 52

Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance

Gassis, S., & Rathod, P. K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.914 · Cited by 48

In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand.

Wongsrichanalai, C., Wimonwattrawatee, T., Sookto, P., Laoboonchai, A., Heppner, D. G., Kyle, D. E., & Wernsdorfer, W. H. (1999) · Europe PMC (PubMed Central) · Cited by 47

In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs

Winstanley, P. A., Mberu, E. K., Szwandt, I. S. F., Breckenridge, A., & Watkins, W. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.948 · Cited by 47

A bifunctional dihydrofolate synthetase–folylpolyglutamate synthetase in Plasmodium falciparum identified by functional complementation in yeast and bacteria

Salcedo, E., Cortese, J. F., Plowe, C. V., Sims, P. F. G., & Hyde, J. E. (2001) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(00)00370-4 · Cited by 46

Plasmodium falciparum:Kinetic Interactions of WR99210 with Pyrimethamine-Sensitive and Pyrimethamine-Resistant Dihydrofolate Reductase

Hekmat-Nejad, M., & Rathod, P. K. (1997) · Experimental Parasitology · doi:10.1006/expr.1997.4228 · Cited by 44

Low-Dose Treatment with Sulfadoxine-Pyrimethamine Combinations Selects for Drug-Resistant Plasmodium falciparum Strains

Kun, J. F. J., Lehman, L. G., Lell, B., Schmidt‐Ott, R., & Kremsner, P. G. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2205 · Cited by 44

Intrinsic Efficacy of Proguanil against Falciparum and Vivax Malaria Independent of the Metabolite Cycloguanil

Kaneko, A., Bergqvist, Y., Takechi, M., Kalkoa, M., Kaneko, O., Kobayakawa, T., Ishizaki, T., & Björkman, A. (1999) · The Journal of Infectious Diseases · doi:10.1086/314683 · Cited by 43

Plasmodium falciparum: selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children.

Jelínek, T., Kilian, A. H. D., Curtis, J., Duraisingh, M. T., Kabagambe, G., von Sonnenburg, F., & Warhurst, D. C. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.125 · Cited by 40

Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected withP. bergheiand‘P. bergheiNS’

Peters, W., & Robinson, B. L. (1984) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1984.11811850 · Cited by 39

Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania

Curtis, J., Duraisingh, M. T., Trigg, J. K., Mbwana, H. A., Warhurst, D. C., & Curtis, C. F. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90432-0 · Cited by 38

Falciparum Malaria: Differential Effects of Antimalarial Drugs on Ex Vivo Parasite Viability during the Critical Early Phase of Therapy

Watkins, W. M., Woodrow, C. J., & Marsh, K. (1993) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.49.106 · Cited by 33

Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitologic resistance versus therapeutic efficacy.

Plowe, C. V., Doumbo, O. K., DJIMDÉ, A. A., Kayentao, K., Diourte, Y., Doumbo, S. N., Coulibaly, D. M., Thera, M. A., Wellems, T. E., & Diallo, D. A. (2001) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.242 · Cited by 32

More on ‘The Efficacy of Antifolate Antimalarial Combinations in Africa'

Watkins, W. M., Mberu, E. K., Winstanley, P. A., & Plowe, C. V. (1999) · Parasitology Today · doi:10.1016/s0169-4758(99)01419-2 · Cited by 32

Malaria chemoprophylaxis with chloroquine in young Nigerian children

Bradley-Moore, A. M., Greenwood, B. M., Bradley, A. K., Akintunde, A., Attai, E. D. E., Fleming, A. F., Flynn, F. V., Kirkwood, B. R., & Gilles, H. M. (1985) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1985.11811965 · Cited by 32

Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance

Mberu, E. K., Nzila, A. M., Nduati, E. W., et al. (2002) · Experimental Parasitology · doi:10.1016/s0014-4894(02)00108-x · Cited by 31

Molecular epidemiology of malaria in Yaounde, Cameroon II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum.

Basco, L. K., & Ringwald, P. (1998) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1998.58.374 · Cited by 29

Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome.

Khalil, I. F., Alifrangis, M., RØNN, A. M., et al. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.67.225 · Cited by 27

The changing response of Plasmodium falciparum to antimalarial drugs in East Africa

Watkins, W. M., Percy, M., Crampton, J. M., Ward, S. A., Koech, D., & Howells, R. E. (1988) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(88)90250-7 · Cited by 27

Selection and Synergy in Plasmodium falciparum

Sims, P. F. G., Wang, P., & Hyde, J. E. (1999) · Parasitology Today · doi:10.1016/s0169-4758(99)01420-9 · Cited by 26

Economic prospects for a new antimalarial drug

Foster, S. D. (1994) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(94)90476-6 · Cited by 26

Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children

Omar, S. A., Bakari, A. G., Owiti, A., et al. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90107-5 · Cited by 25

Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro

Edstein, M. D., Yeo, A. E. T., Kyle, D. E., et al. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90531-3 · Cited by 25

Chlorproguanil-dapsone for treating uncomplicated malaria

Bukirwa, H., Garner, P., & Critchley, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004387.pub2 · Cited by 24

Antimalarial quinones: redox potential dependence of methemoglobin formation and heme release in erythrocytes.

Lopez-Shirley, K., Zhang, F., Gosser, D. K., Scott, M. D., & Meshnick, S. R. (1994) · PubMed · Cited by 22

The mechanism of pyrimethamine resistance inPlasmodium falciparum

Dieckmann, A., & Jung, A. (1986) · Parasitology · doi:10.1017/s0031182000051441 · Cited by 22

Malaria Terminology: Report of a Drafting Committee Appointed by The World Health Organization.

(1954) · Archives of Internal Medicine · doi:10.1001/archinte.1954.00240270161013 · Cited by 20

Cross-resistance between “Daraprim” and Proguanil

Robertson, G. I., Davey, D. G., & Fairley, N. H. (1952) · BMJ · doi:10.1136/bmj.2.4796.1255-a · Cited by 20

On `The Efficacy of Antifolate Antimalarial Combinations in Africa'

Sims, P. F. G., Wang, P., & Hyde, J. E. (1998) · Parasitology Today · doi:10.1016/s0169-4758(97)01203-9 · Cited by 19

Serum and red cell folate levels associated with malarial parasitaemia

Oppenheimer, S., & Cashin, P. (1986) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(86)90232-4 · Cited by 17

RII-RIII chloroquine resistantPlasmodium falciparummalaria from East Africa: studies of thein vivoandin vitroresponse to chloroquine

Jepsen, S. V., Fogh, S., Peterslund, N. A., et al. (1983) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1983.11811723 · Cited by 12

Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy

Murphy, J. R., CLYDE, D. F., Herrington, D. A., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.4.676 · Cited by 9

Sulfa-drug resistance in Plasmodium falciparum

Hyde, J. E., & Sims, P. F. G. (2001) · Trends in Parasitology · doi:10.1016/s1471-4922(01)01949-3 · Cited by 9

Further Studies on Malaria Suppression by Monthly Drug Administration

Miller, M. J. (1957) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1957.6.625 · Cited by 5

Malaria: progress, perils, and prospects for eradication

Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H. I., Alonso, P. L., Collins, F. H., & Duffy, P. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33996 · Cited by 709

Safety and Toxicity of Sulfadoxine/Pyrimethamine: Implications for Malaria Prevention in Pregnancy using Intermittent Preventive Treatment

Peters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007) · Drug Safety · doi:10.2165/00002018-200730060-00003 · Cited by 174

Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance

Harrington, W. E., Mutabingwa, T. K., Kabyemela, E., Fried, M., & Duffy, P. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir376 · Cited by 156

Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations

Sridaran, S., McClintock, S. K., Syphard, L. M., Herman, K. M., Barnwell, J. W., & Udhayakumar, V. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-247 · Cited by 124

Nanoformulations of Albendazole As Effective Anticancer and Antiparasite Agents

Movahedi, F., Li, L., Gu, W., & Xu, Z. P. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0102 · Cited by 34